Report Description

India Olmesartan market is expected to grow at a steady rate during the forecast period. The India Olmesartan market is driven by high growth in incidence of cardiovascular diseases in India. Additionally, favorable government policies and schemes for the manufacturing, promotion and development of drugs, intermediates, and active pharmaceutical ingredients in the country will drive the market in coming years. Also, Olmesartan's physiologic effects results in decreased blood pressure, lower aldosterone levels, reduced cardiac activity which is further expected to boost the demand through FY2026.

The India Olmesartan market is segmented based on dose, source, distribution channel, application, end user, company, and region. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for buying medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the fact that majority of the people have smart phones and mobiles these days and there are various applications, online websites and digital platforms for buying drugs which are very user friendly and quick.

The major players operating in the India Olmesartan market are Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Unichem Laboratories Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Lupin Laboratories Ltd. (Pinnacle), Abbott Healthcare Pvt. Ltd., Morepen Laboratories Ltd., and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India Olmesartan market from FY2016 to FY2019.
  • To estimate and forecast the market size of India Olmesartan market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India Olmesartan market based on dose, source, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India Olmesartan market.
  • To identify drivers and challenges for India Olmesartan market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India Olmesartan market.
  • To identify and analyze the profile of leading players operating in India Olmesartan market.
  • To identify key sustainable strategies adopted by market players in India Olmesartan market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India Olmesartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Olmesartan manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to Olmesartan

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India Olmesartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Olmesartan Market, By Dose:
    • 10 mg
    • 20 mg
    • 40 mg
    • Others
  • India Olmesartan Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Olmesartan Market, By Distribution Channel:
    • Online
    • Offline
  • India Olmesartan Market, By Application:
    • High Blood Pressure
    • Heart Failure
    • Diabetic Kidney Disease Others
  • India Olmesartan Market, By End User:
    • Adult
    • Pediatric
  • India Olmesartan Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India Olmesartan market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Olmesartan market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Olmesartan Market

4.    Executive Summary

5.    Manufacturing Olmesartan

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Olmesartan

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Olmesartan Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Dose (10 mg, 20 mg, 40 mg, Others)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Distribution Channel (Online v/s Offline)

7.2.4.     By Application (High Blood Pressure, Heart Failure, Diabetic Kidney Disease Others)

7.2.5.     By End User (Adult v/s Paediatric)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Glenmark Pharmaceuticals Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Alembic Pharmaceuticals Ltd.

14.1.3.  Cadila Pharmaceuticals Ltd.

14.1.4.  Sun Pharmaceuticals Industries Ltd.

14.1.5.  Unichem Laboratories Ltd.

14.1.6.  Cipla Ltd.

14.1.7.  Torrent Pharmaceuticals Ltd.

14.1.8.  Lupin Laboratories Ltd. (Pinnacle)

14.1.9.  Abbott Healthcare Pvt. Ltd.

14.1.10. Morepen Laboratories Ltd.

15.  Strategic Recommendations

About Us & Disclaimer

Figures and Tables

Frequently asked questions